Indian Company Master Data Made Simple
Zydus Lifesciences Limited
Zydus Lifesciences Limited, formed in 1995, has been in existence for 3. Zydus Lifesciences Limited holds the CIN L24230GJ1995PLC025878 and registration number 25878. The company operates as company limited by shares. Its authorized share capital is ₹172.50 crore. It has a paid-up capital totaling ₹100.62 crore.
Its core business comprises manufacture of other chemical products. Registered under the jurisdiction of Ahmedabad. Zydus Lifesciences Limited’s registered office is at Zydus Corporate Park,scheme No. 63, Survey No. 536 Khoraj(gandhinagar),nr. Vaishnodevi Circ, Le, Ahmedabad, Ahmedabad, Gujarat, India, 382481. Zydus Lifesciences Limited holds an active company status. Its registered PAN is AAACC6253G as per government records. The Legal Entity Identifier assigned to the company is 335800R9O14ORBXLPN13. All official communications can be sent to dhavalsoni@zyduslife.com. At the helm are Nitinkumar Dalsukhray Parekh (CFO).
Company Overview
- CIN
- Date of Incorporation
- 14/05/1995
- Company Status
- Active
- RoC
- Ahmedabad
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- LEI Status
- Issued
- Authorized Capital
- ₹1,72,50,00,000.00
- Paid up Capital
- ₹1,00,62,33,990.00
- Activity
- Manufacture of other chemical products
- dhavalsoni@zyduslife.com
- PAN
GST Numbers
| State | GST Number | Status |
|---|---|---|
| Assam | 18AAACC6253G1ZS | Active |
| 18AAACC6253G4ZP | Inactive | |
| 18AAACC6253G3ZQ | Inactive | |
| 18AAACC6253G2ZR | Inactive | |
| Andhra Pradesh | 37AAACC6253G1ZS | Active |
| Bihar | 10AAACC6253G1Z8 | Active |
| 10AAACC6253G2Z7 | Inactive | |
| Chandigarh | 04AAACC6253G1Z1 | Inactive |
| Chhattisgarh | 22AAACC6253G1Z3 | Active |
| Daman and Diu | 25AAACC6253G1ZX | Inactive |
ISIN Numbers
| ISIN | Security | Interest Rate | Maturity Date | FISN | CFI |
|---|---|---|---|---|---|
| INE010B01027 | ZYDUS LIFESCIENCES LIMITED EQ NEW FV RE. 1/- | - | 12/10/2026 | ZYDUS LIFE/SH VTG | ESVUFN |
| IN8010B01026 | ZYDUS LIFESCIENCES LIMITED EQ NEW FV RE. 1/-LISTING /TRADG APRVL AWAITED | - | 12/10/2026 | ZYDUS LIFE/SH VTG | ESVUFN |
Balance Sheet
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net PPE | ₹10,72,970.00L | ₹7,55,970.00L | ₹7,04,920.00L | ₹6,97,310.00L | ₹0.00L |
| Net Debt | ₹10,91,430.00L | ₹2,34,270.00L | ₹35,560.00L | ₹67,540.00L | ₹0.00L |
| Goodwill | ₹7,54,270.00L | ₹5,24,210.00L | ₹5,26,600.00L | ₹4,80,440.00L | ₹0.00L |
| Gross PPE | ₹17,15,420.00L | ₹13,17,940.00L | ₹12,13,100.00L | ₹11,47,570.00L | ₹0.00L |
| Inventory | ₹5,62,810.00L | ₹3,94,400.00L | ₹3,44,190.00L | ₹3,41,330.00L | ₹0.00L |
| Total Debt | ₹12,49,600.00L | ₹3,21,320.00L | ₹80,420.00L | ₹1,19,490.00L | ₹0.00L |
| Common Stock | ₹10,060.00L | ₹10,060.00L | ₹10,060.00L | ₹10,120.00L | ₹0.00L |
| Current Debt | ₹8,58,150.00L | ₹3,16,950.00L | ₹76,860.00L | ₹1,16,320.00L | ₹0.00L |
| Share Issued | ₹10,062.34L | ₹10,062.34L | ₹10,062.34L | ₹10,122.04L | ₹0.00L |
| Total Assets | ₹52,40,660.00L | ₹37,20,170.00L | ₹29,28,080.00L | ₹25,75,640.00L | ₹0.00L |
| Capital Stock | ₹10,060.00L | ₹10,060.00L | ₹10,060.00L | ₹10,120.00L | ₹0.00L |
| Long Term Debt | ₹3,18,800.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Current Assets | ₹19,90,610.00L | ₹17,04,610.00L | ₹11,50,140.00L | ₹10,01,640.00L | ₹0.00L |
| Prepaid Assets | ₹1,40,810.00L | ₹65,620.00L | ₹71,900.00L | ₹72,960.00L | ₹0.00L |
| Working Capital | ₹4,19,420.00L | ₹8,00,450.00L | ₹6,15,950.00L | ₹4,48,570.00L | ₹0.00L |
| Invested Capital | ₹38,88,090.00L | ₹27,12,260.00L | ₹20,59,810.00L | ₹18,67,900.00L | ₹0.00L |
| Other Properties | ₹9,23,070.00L | ₹6,04,200.00L | ₹5,80,330.00L | ₹5,69,650.00L | ₹0.00L |
| Retained Earnings | ₹28,48,790.00L | ₹24,56,160.00L | ₹20,36,900.00L | ₹17,18,980.00L | ₹0.00L |
| Common Stock Equity | ₹27,11,140.00L | ₹23,95,310.00L | ₹19,82,950.00L | ₹17,51,580.00L | ₹0.00L |
| Net Tangible Assets | ₹9,70,350.00L | ₹15,48,740.00L | ₹11,95,250.00L | ₹11,62,090.00L | ₹0.00L |
| Tangible Book Value | ₹9,70,350.00L | ₹15,48,740.00L | ₹11,95,250.00L | ₹11,62,090.00L | ₹0.00L |
| Current Liabilities | ₹15,71,190.00L | ₹9,04,160.00L | ₹5,34,190.00L | ₹5,53,070.00L | ₹0.00L |
| Long Term Provisions | ₹44,530.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Stockholders Equity | ₹27,11,140.00L | ₹23,95,310.00L | ₹19,82,950.00L | ₹17,51,580.00L | ₹0.00L |
| Other Equity Interest | ₹27,01,080.00L | ₹23,85,250.00L | ₹19,72,890.00L | ₹17,41,460.00L | ₹0.00L |
| Total Capitalization | ₹30,29,940.00L | ₹23,95,310.00L | ₹19,82,950.00L | ₹17,51,580.00L | ₹0.00L |
| Hedging Assets Current | ₹2,380.00L | ₹1,780.00L | ₹28,030.00L | ₹0.00L | ₹0.00L |
| Ordinary Shares Number | ₹10,062.34L | ₹10,062.34L | ₹10,062.34L | ₹10,122.04L | ₹0.00L |
| Other Intangible Assets | ₹9,86,520.00L | ₹3,22,360.00L | ₹2,61,100.00L | ₹1,09,050.00L | ₹0.00L |
| Other Non Current Assets | ₹4,020.00L | ₹2,160.00L | ₹2,100.00L | ₹1,810.00L | ₹0.00L |
| Total Non Current Assets | ₹32,50,050.00L | ₹20,15,560.00L | ₹17,77,940.00L | ₹15,74,000.00L | ₹0.00L |
| Cash And Cash Equivalents | ₹85,520.00L | ₹82,680.00L | ₹41,300.00L | ₹48,780.00L | ₹0.00L |
| Construction In Progress | ₹1,49,900.00L | ₹1,51,770.00L | ₹1,24,590.00L | ₹1,27,660.00L | ₹0.00L |
| Accumulated Depreciation | -₹6,42,450.00L | -₹5,61,970.00L | -₹5,08,180.00L | -₹4,50,260.00L | ₹0.00L |
| Additional Paid In Capital | ₹180.00L | ₹180.00L | ₹180.00L | ₹120.00L | ₹0.00L |
| Other Short Term Investments | ₹4,11,590.00L | ₹4,81,480.00L | ₹96,670.00L | ₹71,880.00L | ₹0.00L |
| Other Non Current Liabilities | ₹50.00L | ₹90.00L | ₹180.00L | ₹0.00L | ₹30.00L |
| Machinery Furniture Equipment | ₹10,72,320.00L | ₹8,64,600.00L | ₹8,07,750.00L | ₹7,49,850.00L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹17,40,790.00L | ₹8,46,570.00L | ₹7,87,700.00L | ₹5,89,490.00L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹29,58,220.00L | ₹26,35,840.00L | ₹22,10,160.00L | ₹19,68,830.00L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹22,82,440.00L | ₹10,84,330.00L | ₹7,17,920.00L | ₹6,06,810.00L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹8,63,970.00L | ₹3,18,110.00L | ₹77,910.00L | ₹1,17,510.00L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹3,85,630.00L | ₹3,210.00L | ₹2,510.00L | ₹1,980.00L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹4,97,110.00L | ₹5,64,160.00L | ₹1,37,970.00L | ₹1,20,660.00L | ₹0.00L |
| Total Non Current Liabilities Net Minority Interest | ₹7,11,250.00L | ₹1,80,170.00L | ₹1,83,730.00L | ₹53,740.00L | ₹0.00L |
Cash Flow
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net Income | ₹5,04,000.00L | ₹4,52,550.00L | ₹3,85,950.00L | ₹1,96,030.00L | ₹0.00L |
| Free Cash Flow | -₹55,490.00L | ₹5,08,740.00L | ₹2,28,970.00L | ₹1,65,790.00L | ₹0.00L |
| Changes In Cash | -₹37,260.00L | ₹41,860.00L | -₹5,770.00L | -₹17,660.00L | ₹0.00L |
| End Cash Position | ₹85,520.00L | ₹82,680.00L | ₹41,300.00L | ₹48,780.00L | ₹0.00L |
| Financing Cash Flow | ₹5,80,690.00L | ₹1,99,530.00L | -₹1,77,880.00L | -₹4,40,040.00L | ₹0.00L |
| Investing Cash Flow | -₹8,29,610.00L | -₹8,35,780.00L | -₹1,47,520.00L | ₹1,53,500.00L | ₹0.00L |
| Operating Cash Flow | ₹2,11,660.00L | ₹6,78,110.00L | ₹3,19,630.00L | ₹2,68,880.00L | ₹0.00L |
| Capital Expenditure | -₹2,67,150.00L | -₹1,69,370.00L | -₹90,660.00L | -₹1,03,090.00L | ₹0.00L |
| Beginning Cash Position | ₹82,680.00L | ₹41,300.00L | ₹48,780.00L | ₹65,780.00L | ₹0.00L |
| Other Cash Adjustment Outside Changein Cash | ₹19,020.00L | ₹1,660.00L | ₹600.00L | ₹0.00L | -₹2,590.00L |
Income Statement
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| EBIT | ₹6,98,610.00L | ₹6,12,020.00L | ₹4,85,290.00L | ₹2,71,520.00L | ₹0.00L |
| Ebit | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| EBITDA | ₹8,39,410.00L | ₹7,03,600.00L | ₹5,61,700.00L | ₹3,43,790.00L | ₹0.00L |
| Basic EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income | ₹5,04,000.00L | ₹4,52,550.00L | ₹3,85,950.00L | ₹1,96,030.00L | ₹0.00L |
| Diluted EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Gross Profit | ₹19,06,050.00L | ₹15,90,740.00L | ₹12,52,110.00L | ₹10,31,890.00L | ₹0.00L |
| Pretax Income | ₹6,62,110.00L | ₹6,02,670.00L | ₹4,80,890.00L | ₹2,58,970.00L | ₹0.00L |
| Tax Provision | ₹1,59,470.00L | ₹1,41,190.00L | ₹97,750.00L | ₹58,780.00L | ₹0.00L |
| Total Revenue | ₹26,71,970.00L | ₹22,57,380.00L | ₹19,02,150.00L | ₹16,87,780.00L | ₹0.00L |
| Cost Of Revenue | ₹7,65,920.00L | ₹6,66,640.00L | ₹6,50,040.00L | ₹6,55,890.00L | ₹0.00L |
| Total Expenses | ₹20,93,310.00L | ₹16,59,450.00L | ₹14,48,230.00L | ₹14,02,500.00L | ₹0.00L |
| Interest Income | ₹42,250.00L | ₹18,520.00L | ₹12,680.00L | ₹7,570.00L | ₹0.00L |
| Interest Expense | ₹36,500.00L | ₹9,350.00L | ₹4,400.00L | ₹12,550.00L | ₹0.00L |
| Operating Income | ₹5,78,660.00L | ₹5,97,930.00L | ₹4,53,920.00L | ₹2,85,280.00L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Income Tax Expense | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized EBITDA | ₹8,90,390.00L | ₹7,11,280.00L | ₹5,51,090.00L | ₹3,34,180.00L | ₹0.00L |
| Normalized Income | ₹5,42,701.40L | ₹4,82,268.07L | ₹3,75,196.68L | ₹2,94,396.59L | ₹0.00L |
| Operating Expense | ₹13,27,390.00L | ₹9,92,810.00L | ₹7,98,190.00L | ₹7,46,610.00L | ₹0.00L |
| Operating Revenue | ₹26,71,970.00L | ₹22,57,380.00L | ₹19,02,150.00L | ₹16,87,780.00L | ₹0.00L |
| Net Interest Income | ₹4,660.00L | ₹8,590.00L | ₹7,760.00L | -₹5,410.00L | ₹0.00L |
| Total Unusual Items | -₹50,980.00L | -₹7,680.00L | ₹10,610.00L | ₹9,610.00L | ₹0.00L |
| Basic Average Shares | ₹10,062.34L | ₹10,062.34L | ₹10,119.27L | ₹10,156.50L | ₹0.00L |
| Diluted Average Shares | ₹10,062.34L | ₹10,062.34L | ₹10,119.27L | ₹10,156.50L | ₹0.00L |
| Total Other Finance Cost | ₹1,090.00L | ₹580.00L | ₹520.00L | ₹430.00L | ₹0.00L |
| Other Operating Expenses | ₹3,21,600.00L | ₹2,56,410.00L | ₹2,24,470.00L | ₹2,03,480.00L | ₹0.00L |
| Reconciled Depreciation | ₹1,40,800.00L | ₹91,580.00L | ₹76,410.00L | ₹72,270.00L | ₹0.00L |
| Total Operating Expenses | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹7,65,920.00L | ₹6,66,640.00L | ₹6,50,040.00L | ₹6,55,890.00L | ₹0.00L |
| Rent Expense Supplemental | ₹5,140.00L | ₹3,060.00L | ₹2,610.00L | ₹2,290.00L | ₹0.00L |
| Tax Effect Of Unusual Items | -₹12,278.60L | -₹4,961.93L | ₹2,156.68L | -₹11,303.41L | ₹0.00L |
| Interest Income Non Operating | ₹42,250.00L | ₹18,520.00L | ₹12,680.00L | ₹7,570.00L | ₹0.00L |
| Selling And Marketing Expense | ₹3,30,240.00L | ₹2,05,340.00L | ₹1,65,800.00L | ₹1,55,720.00L | ₹0.00L |
| Interest Expense Non Operating | ₹36,500.00L | ₹9,350.00L | ₹4,400.00L | ₹12,550.00L | ₹0.00L |
| Net Income Common Stockholders | ₹5,04,000.00L | ₹4,52,550.00L | ₹3,85,950.00L | ₹1,96,030.00L | ₹0.00L |
| Net Income Continuous Operations | ₹5,12,350.00L | ₹4,67,260.00L | ₹3,94,980.00L | ₹2,09,650.00L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | ₹5,04,000.00L | ₹4,52,550.00L | ₹3,85,950.00L | ₹1,96,030.00L | ₹0.00L |
| General And Administrative Expense | ₹71,520.00L | ₹81,350.00L | ₹51,760.00L | ₹58,290.00L | ₹0.00L |
| Selling General And Administration | ₹4,01,760.00L | ₹2,86,690.00L | ₹2,17,560.00L | ₹2,14,010.00L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | -₹50,980.00L | -₹21,180.00L | ₹10,610.00L | -₹49,800.00L | ₹0.00L |
| Net Non Operating Interest Income Expense | ₹4,660.00L | ₹8,590.00L | ₹7,760.00L | -₹5,410.00L | ₹0.00L |
| Net Income Including Noncontrolling Interests | ₹5,12,350.00L | ₹4,67,260.00L | ₹3,97,280.00L | ₹2,09,190.00L | ₹0.00L |
| Net Income From Continuing And Discontinued Operation | ₹5,04,000.00L | ₹4,52,550.00L | ₹3,85,950.00L | ₹1,96,030.00L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | ₹5,04,000.00L | ₹4,52,550.00L | ₹3,83,650.00L | ₹1,96,490.00L | ₹0.00L |
Company Performance (FY23–FY26)
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 15/05/1995 | Pankaj Ramanbhai Patel | 00131852 | Director | View other directorships |
| 01/08/1997 | Mukesh Mangalbhai Patel | 00053892 | Director | View other directorships |
| 01/08/1997 | Sharvil Pankajbhai Patel | 00131995 | Managing Director | View other directorships |
| 10/02/2015 | Nitinkumar Dalsukhray Parekh | *****6584E | CFO | |
| 13/05/2016 | Apurva Shishir Diwanji | 00032072 | Director | View other directorships |
| 12/07/2017 | Ganesh Narayan Nayak | 00017481 | Whole-time director | View other directorships |
| 06/12/2018 | Bhadresh Kantilal Shah | 00058177 | Director | View other directorships |
| 07/02/2019 | Dhaval Narendra Soni | *****0561P | Company Secretary | |
| 29/11/2022 | Monappa Arun Akhil | 09784366 | Director | View other directorships |
| 29/11/2022 | Upasana Konidela | 02781278 | Director | View other directorships |
| 17/05/2024 | Shelina Pranav Parikh | 00468199 | Director | View other directorships |
Business Network
Directors 11
- Sharvil Pankajbhai PatelManaging Director
- Ganesh Narayan NayakWhole-time director
- Shelina Pranav ParikhDirector
- Monappa Arun AkhilDirector
- Upasana KonidelaDirector
- Bhadresh Kantilal ShahDirector
- Apurva Shishir DiwanjiDirector
- Mukesh Mangalbhai PatelDirector
- Pankaj Ramanbhai PatelDirector
- Dhaval Narendra SoniCompany Secretary
- Nitinkumar Dalsukhray ParekhCFO
Subsidiaries 6
- Alidac Pharmaceuticals LimitedDirect
- Zydus Medtech Private LimitedDirect
- Zydus Wellness LimitedDirect
- Zydus Pharmaceuticals LimitedDirect
- Zydus Vtec LimitedDirect
- Zydus Wellness Products LimitedUltimate
Latest Documents
| Date | Title | Size |
|---|---|---|
| 03/10/2024 | Form MGT-7-03102024_signed | - |
| 20/09/2024 | Form AOC-4(XBRL)-20092024-signed | - |
| 22/02/2024 | Form Addendum to AOC-4 CSR-22022024_signed | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Dabur India Limited | L24230DL1975PLC007908 | 8/3 Asaf Ali Road, New Delhi, Delhi, India, 110002 |
| Gujchem Distillers India Limited | L24230GJ1939PLC002480 | - |
| Ind Swift Limited | L24230CH1986PLC006897 | 781industrial Area Phase Ii, Chandigarh, Chandigarh, India, 160002 |
| Lyka Labs Limited | L24230GJ1976PLC008738 | 4801/b & 4802/a Gidc Indutrail Estate, Ankleshwar, Gujarat, India, 393002 |
| Torrent Pharmaceuticals Ltd | L24230GJ1972PLC002126 | Torrent Houseoff Ashram Road Navarangpura 9, Ahmedabad, Gujarat, India, 000000 |
Direct/Ultimate Children
| Type | Legal Name | LEI code |
|---|---|---|
| Direct | Alidac Pharmaceuticals Limited | 3358006X6DZZOB1IN950 |
| Direct | Zydus Medtech Private Limited | 335800V3GJU7D9PFAT14 |
| Direct | Zydus Wellness Limited | 335800YCS4FG8P1D1Y21 |
| Direct | Zydus Pharmaceuticals Limited | 9845006954K37BCB6F20 |
| Direct | Zydus Vtec Limited | 984500AEFE84BU974E43 |
| Ultimate | Zydus Wellness Products Limited | 335800IF6SI1C8EYNJ07 |
Address
Frequently Asked Questions
The current board member of Zydus Lifesciences Limited are:
- Mukesh Mangalbhai Patel
- Apurva Shishir Diwanji
- Ganesh Narayan Nayak
- Pankaj Ramanbhai Patel
- Sharvil Pankajbhai Patel
- Bhadresh Kantilal Shah
- Monappa Arun Akhil
- Upasana Konidela
- Shelina Pranav Parikh